Global and China Predictive Biomarkers Market Size, Status and Forecast 2020-2026

1 Report Overview

• 1.1 Study Scope
• 1.2 Market Analysis by Type
  • 1.2.1 Global Predictive Biomarkers Market Size Growth Rate by Type: 2020 VS 2026
  • 1.2.2 Cancer
  • 1.2.3 Neurological Disorder
  • 1.2.4 Cardiovascular Disorder
  • 1.2.5 Immunological Disorder
  • 1.2.6 Others
• 1.3 Market by Application
  • 1.3.1 Global Predictive Biomarkers Market Share by Application: 2020 VS 2026
  • 1.3.2 Diagnostic Centers
  • 1.3.3 Academic Research Institutes
  • 1.3.4 CRO’S
  • 1.3.5 Bio-Pharmaceutical Companies
• 1.4 Study Objectives
• 1.5 Years Considered

2 Global Growth Trends

• 2.1 Global Predictive Biomarkers Market Perspective (2015-2026)
• 2.2 Global Predictive Biomarkers Growth Trends by Regions
  • 2.2.1 Predictive Biomarkers Market Size by Regions: 2015 VS 2020 VS 2026
  • 2.2.2 Predictive Biomarkers Historic Market Share by Regions (2015-2020)
  • 2.2.3 Predictive Biomarkers Forecasted Market Size by Regions (2021-2026)
• 2.3 Industry Trends and Growth Strategy
  • 2.3.1 Market Trends
  • 2.3.2 Market Drivers
  • 2.3.3 Market Challenges
  • 2.3.4 Market Restraints

3 Competition Landscape by Key Players

• 3.1 Global Top Predictive Biomarkers Players by Market Size
  • 3.1.1 Global Top Predictive Biomarkers Players by Revenue (2015-2020)
  • 3.1.2 Global Predictive Biomarkers Revenue Market Share by Players (2015-2020)
• 3.2 Global Predictive Biomarkers Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
• 3.3 Players Covered: Ranking by Predictive Biomarkers Revenue
• 3.4 Global Predictive Biomarkers Market Concentration Ratio
  • 3.4.1 Global Predictive Biomarkers Market Concentration Ratio (CR5 and HHI)
  • 3.4.2 Global Top 10 and Top 5 Companies by Predictive Biomarkers Revenue in 2019
• 3.5 Key Players Predictive Biomarkers Area Served
• 3.6 Key Players Predictive Biomarkers Product Solution and Service
• 3.7 Date of Enter into Predictive Biomarkers Market
• 3.8 Mergers & Acquisitions, Expansion Plans

4 Predictive Biomarkers Breakdown Data by Type (2015-2026)

• 4.1 Global Predictive Biomarkers Historic Market Size by Type (2015-2020)
• 4.2 Global Predictive Biomarkers Forecasted Market Size by Type (2021-2026)

5 Predictive Biomarkers Breakdown Data by Application (2015-2026)

• 5.1 Global Predictive Biomarkers Historic Market Size by Application (2015-2020)
• 5.2 Global Predictive Biomarkers Forecasted Market Size by Application (2021-2026)

6 North America

• 6.1 North America Predictive Biomarkers Market Size (2015-2026)
• 6.2 North America Predictive Biomarkers Market Size by Type (2015-2020)
• 6.3 North America Predictive Biomarkers Market Size by Application (2015-2020)
• 6.4 North America Predictive Biomarkers Market Size by Country (2015-2020)
  • 6.4.1 United States
  • 6.4.2 Canada

7 Europe

• 7.1 Europe Predictive Biomarkers Market Size (2015-2026)
• 7.2 Europe Predictive Biomarkers Market Size by Type (2015-2020)
• 7.3 Europe Predictive Biomarkers Market Size by Application (2015-2020)
• 7.4 Europe Predictive Biomarkers Market Size by Country (2015-2020)
  • 7.4.1 Germany
  • 7.4.2 France
  • 7.4.3 U.K.
  • 7.4.4 Italy
  • 7.4.5 Russia
  • 7.4.6 Nordic
  • 7.4.7 Rest of Europe

8 China

• 8.1 China Predictive Biomarkers Market Size (2015-2026)
• 8.2 China Predictive Biomarkers Market Size by Type (2015-2020)
• 8.3 China Predictive Biomarkers Market Size by Application (2015-2020)
• 8.4 China Predictive Biomarkers Market Size by Region (2015-2020)
  • 8.4.1 China
  • 8.4.2 Japan
  • 8.4.3 South Korea
  • 8.4.4 Southeast Asia
  • 8.4.5 India
  • 8.4.6 Australia
  • 8.4.7 Rest of Asia-Pacific

9 Japan

• 9.1 Japan Predictive Biomarkers Market Size (2015-2026)
• 9.2 Japan Predictive Biomarkers Market Size by Type (2015-2020)
• 9.3 Japan Predictive Biomarkers Market Size by Application (2015-2020)
• 9.4 Japan Predictive Biomarkers Market Size by Country (2015-2020)
  • 9.4.1 Mexico
  • 9.4.2 Brazil

10 Southeast Asia

• 10.1 Southeast Asia Predictive Biomarkers Market Size (2015-2026)
• 10.2 Southeast Asia Predictive Biomarkers Market Size by Type (2015-2020)
• 10.3 Southeast Asia Predictive Biomarkers Market Size by Application (2015-2020)
• 10.4 Southeast Asia Predictive Biomarkers Market Size by Country (2015-2020)
  • 10.4.1 Turkey
  • 10.4.2 Saudi Arabia
  • 10.4.3 UAE
  • 10.4.4 Rest of Middle East & Africa

11 Key Players Profiles

• 11.1 Siemens Healthcare
  • 11.1.1 Siemens Healthcare Company Details
  • 11.1.2 Siemens Healthcare Business Overview
  • 11.1.3 Siemens Healthcare Predictive Biomarkers Introduction
  • 11.1.4 Siemens Healthcare Revenue in Predictive Biomarkers Business (2015-2020))
  • 11.1.5 Siemens Healthcare Recent Development
• 11.2 Roche Diagnostic
  • 11.2.1 Roche Diagnostic Company Details
  • 11.2.2 Roche Diagnostic Business Overview
  • 11.2.3 Roche Diagnostic Predictive Biomarkers Introduction
  • 11.2.4 Roche Diagnostic Revenue in Predictive Biomarkers Business (2015-2020)
  • 11.2.5 Roche Diagnostic Recent Development
• 11.3 G.E. Healthcare
  • 11.3.1 G.E. Healthcare Company Details
  • 11.3.2 G.E. Healthcare Business Overview
  • 11.3.3 G.E. Healthcare Predictive Biomarkers Introduction
  • 11.3.4 G.E. Healthcare Revenue in Predictive Biomarkers Business (2015-2020)
  • 11.3.5 G.E. Healthcare Recent Development
• 11.4 Abbott Laboratories
  • 11.4.1 Abbott Laboratories Company Details
  • 11.4.2 Abbott Laboratories Business Overview
  • 11.4.3 Abbott Laboratories Predictive Biomarkers Introduction
  • 11.4.4 Abbott Laboratories Revenue in Predictive Biomarkers Business (2015-2020)
  • 11.4.5 Abbott Laboratories Recent Development
• 11.5 Qiagen
  • 11.5.1 Qiagen Company Details
  • 11.5.2 Qiagen Business Overview
  • 11.5.3 Qiagen Predictive Biomarkers Introduction
  • 11.5.4 Qiagen Revenue in Predictive Biomarkers Business (2015-2020)
  • 11.5.5 Qiagen Recent Development
• 11.6 Johnson and Johnson
  • 11.6.1 Johnson and Johnson Company Details
  • 11.6.2 Johnson and Johnson Business Overview
  • 11.6.3 Johnson and Johnson Predictive Biomarkers Introduction
  • 11.6.4 Johnson and Johnson Revenue in Predictive Biomarkers Business (2015-2020)
  • 11.6.5 Johnson and Johnson Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

• 13.1 Research Methodology
  • 13.1.1 Methodology/Research Approach
  • 13.1.2 Data Source
• 13.2 Disclaimer